Get the Stockscreener App
10.21
2.20%
0.22
After Hours:
10.21
Fennec Pharmaceuticals Inc stock is traded at $10.21, with a volume of 115.54K.
It is up +2.20% in the last 24 hours and down -7.35% over the past month.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
See More
Previous Close:
$9.99
Open:
$10.59
24h Volume:
115.54K
Relative Volume:
0.44
Market Cap:
$354.67M
Revenue:
$51.00M
Net Income/Loss:
$-8.73M
P/E Ratio:
-34.47
EPS:
-0.2962
Net Cash Flow:
$-7.75M
1W Performance:
+3.13%
1M Performance:
-7.35%
6M Performance:
+30.06%
1Y Performance:
+18.31%
1-Day Range:
$10.01
$10.59
1-Week Range:
$9.7762
$10.75
52-Week Range:
$5.65
$11.31
Fennec Pharmaceuticals Inc Stock (FENC) Company Profile
Name
Fennec Pharmaceuticals Inc
Sector
Industry
Phone
(919) 636-4530
Address
PO BOX 13628, RESEARCH TRIANGLE PARK, NC
Compare FENC vs VRTX, REGN, ARGX, RVMD, ALNY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
FENC
Fennec Pharmaceuticals Inc
|
10.21 | 347.02M | 51.00M | -8.73M | -7.75M | -0.2962 |
VRTX
Vertex Pharmaceuticals Inc
|
479.00 | 121.16B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
667.17 | 68.78B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
888.82 | 57.44B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
188.07 | 40.23B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.40 | 36.28B | 4.29B | 577.22M | 641.34M | 4.2086 |
Fennec Pharmaceuticals Inc Stock (FENC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-12-26 | Initiated | B. Riley Securities | Buy |
| Jan-09-26 | Initiated | Piper Sandler | Overweight |
| Nov-22-22 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Sep-07-22 | Initiated | CapitalOne | Overweight |
| Aug-08-22 | Resumed | Craig Hallum | Buy |
| Jun-05-20 | Initiated | Cantor Fitzgerald | Overweight |
| Oct-11-18 | Initiated | Goldman | Buy |
View All
Fennec Pharmaceuticals Inc Stock (FENC) Latest News
Fennec Pharmaceuticals Inc (FENC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
FENC|Fennec Pharmaceuticals Inc|Price:10.205|Chg%:+0.215 - TradingKey
Fennec Pharmaceuticals Inc (FENC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
FENC|Fennec Pharmaceuticals Inc|Price:10.280|Chg%:+0.290 - TradingKey
Fennec Pharmaceuticals Inc - TradingKey
Fennec Pharmaceuticals Inc. Revenue Breakdown – TSX:FRX - TradingView
Fennec Pharmaceuticals(FENC) Stock Options Chain | Quotes & News - Moomoo
FENC|Fennec Pharmaceuticals Inc|Price:9.990| - TradingKey
Fennec Pharmaceuticals Inc (FENC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
What's Going On With Fennec Pharmaceuticals Inc Stock Tuesday? - Wealth Awesome
US Generic Drug Stocks With Domestic Manufacturing in Focus - Sahm
Why Fennec Pharmaceuticals Inc stock is sliding today - Wealth Awesome
What's Going On With Fennec Pharmaceuticals Inc Stock Wednesday? - Wealth Awesome
Why Fennec Pharmaceuticals Inc stock is rising today - Wealth Awesome
Understanding the Setup: (FENC) and Scalable Risk - Stock Traders Daily
Why Fennec Pharmaceuticals Inc stock is plummeting today - Wealth Awesome
Fennec Pharmaceuticals Company Profile & Introduction - Moomoo
Fennec (NASDAQ: FENC) ex-director exercises options, sells shares for taxes - Stock Titan
Form 144 FENNEC PHARMACEUTICALS INC. For: 1 July By Investing.com - Investing.com India
Fennec Pharmaceuticals (FENC) CCO receives 168-share award, holds 21,183 - Stock Titan
Fennec (NASDAQ: FENC) CMO awarded 168 shares, holds 21,183 - Stock Titan
Fennec Pharmaceuticals (NASDAQ: FENC) CEO reports 1,159-share award release - Stock Titan
FENNEC (FENC) CFO Andrade gains 1,703 vested shares, now holds 290,972 - Stock Titan
Fennec (NASDAQ: FENC) Chief Strategy Officer receives 156-share stock award - Stock Titan
FENC (NASDAQ: FENC) plans 9,599-share option sale; prior small sales listed - Stock Titan
Fennec Pharmaceuticals Inc.(NasdaqCM:FENC) dropped from Russell 2000 Value Benchmark - marketscreener.com
Fennec Pharmaceuticals Inc.(NasdaqCM:FENC) dropped from Russell Microcap Value Benchmark Index - marketscreener.com
Fennec Pharmaceuticals Inc.(NasdaqCM:FENC) dropped from Russell 2500 Value Benchmark - marketscreener.com
Fennec Pharmaceuticals Inc.(NasdaqCM:FENC) dropped from Russell Small Cap Comp Value Benchmark - marketscreener.com
Enterprise value to EBITDA forward of Fennec Pharmaceuticals Inc. – NASDAQ:FENC - TradingView
Enterprise value to EBIT forward of Fennec Pharmaceuticals Inc. – NASDAQ:FENC - TradingView
Fennec Pharmaceuticals Hits Day High with 13.96% Surge in Stock Price - MarketsMojo
Enterprise value to EBIT forward of Fennec Pharmaceuticals Inc. – FWB:RV41 - TradingView
Enterprise value to EBITDA forward of Fennec Pharmaceuticals Inc. – FWB:RV41 - TradingView
Fennec Pharmaceuticals (FENC) Surges 4.45% as Bullish Momentum BuildsGamma Flip Level - dars.gov.et
Price to earnings forward of Fennec Pharmaceuticals Inc. – NASDAQ:FENC - TradingView
Fennec Pharmaceuticals Inc. Actuals & Estimates (TSX:FRX) - TradingView
RV41 Forecast — Price Target — Prediction for 2027 - TradingView
Price to sales forward of Fennec Pharmaceuticals Inc. – NASDAQ:FENC - TradingView
Price to book forward of Fennec Pharmaceuticals Inc. – NASDAQ:FENC - TradingView
Fennec Pharmaceuticals Inc. Actuals & Estimates (LS:A12A5F) - TradingView
Enterprise value to revenue forward of Fennec Pharmaceuticals Inc. – NASDAQ:FENC - TradingView
Fennec Pharmaceuticals Inc. Actuals & Estimates (BOATS:FENC) - TradingView
FENC Forecast — Price Target — Prediction for 2027 - TradingView
A12A5F Forecast — Price Target — Prediction for 2027 - TradingView
Price to book forward of Fennec Pharmaceuticals Inc. – BOATS:FENC - TradingView
Price to earnings forward of Fennec Pharmaceuticals Inc. – BOATS:FENC - TradingView
Enterprise value to EBIT forward of Fennec Pharmaceuticals Inc. – BOATS:FENC - TradingView
Why Fennec Pharmaceuticals Inc stock is skyrocketing today - Wealth Awesome
Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - The Manila Times
Fennec Pharmaceuticals (FENC) Gains Ground, Testing Near-Term ResistanceAnalyst Upgrade Stocks - dars.gov.et
Fennec Pharmaceuticals Inc Stock (FENC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.97%
0.83%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):